Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,9902 USD | -1,96% |
|
+2,05% | +80,00% |
13/06 | Xilio Therapeutics, Inc. Kondigt bestuursbenoemingen aan | CI |
14/05 | Xilio Therapeutics, Inc. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024 | CI |
Vakgebied
Aantal werknemers: 56
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
René Russo
CEO | Chief Executive Officer | 49 | 22-05-19 |
Kevin Brennan
DFI | Director of Finance/CFO | 54 | - |
Chief Tech/Sci/R&D Officer | - | 01-10-22 | |
Chief Operating Officer | 42 | 01-03-21 | |
Uli Bialucha
CTO | Chief Tech/Sci/R&D Officer | - | 01-04-21 |
Scott Coleman
PRN | Corporate Officer/Principal | - | 01-06-22 |
Stacey J. Davis
PRN | Corporate Officer/Principal | - | 17-05-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paul Clancy
CHM | Chairman | 62 | 23-07-20 |
Daniel Curran
BRD | Director/Board Member | 57 | 01-12-20 |
Sara Bonstein
BRD | Director/Board Member | 43 | 17-08-21 |
Robert Ross
BRD | Director/Board Member | 50 | 16-06-22 |
René Russo
CEO | Chief Executive Officer | 49 | 22-05-19 |
Christina Rossi
BRD | Director/Board Member | 48 | 01-04-21 |
Yuan Xu
BRD | Director/Board Member | 56 | 04-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 36 912 373 | 27 391 601 ( 74,21 %) | 0 | 74,21 % |
Bedrijfsgegevens
![Adres Xilio Therapeutics, Inc.(XLO)](https://cdn.zonebourse.com/static/address/128506326.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+80,00% | 37,28 mln. | |
+25,38% | 46,56 mld. | |
+45,38% | 41,67 mld. | |
+0,78% | 41,16 mld. | |
+30,68% | 32,4 mld. | |
+22,19% | 28,18 mld. | |
-6,35% | 28,1 mld. | |
+49,05% | 14,52 mld. | |
+48,21% | 13,74 mld. | |
+3,53% | 12,17 mld. |